Concord Drugs Ltd
company logo

Concord Drugs Ltd

CONCORDDRUGS Share Price

BSE:538965

71

-1.80 (-2.47%)

As on April 2, 2026 at 04:00 PM
Loading chart...

Performance

Loading performance...

72.80

70.64

2358

0.02

10

Fundamentals

71Cr

124.56

2.06

0.54

0.57

0%

34.42

About

Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The Company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.

1995

NameDesignation
S Nagi ReddyChairman / Executive Director / M D / Promoter
Koni ReddyED / WTD / CFO / Promoter
S. Manoj Kumar ReddyWTD & Executive Director
K Ramchandra ReddyIndependent Non Exe. Director
Summela KasuIndependent Non Exe. Director
S. Nagavenkata HareeshIndependent Non Exe. Director
Satyam Reddy GopidiIndependent Non Exe. Director
NamrathaCompany Sec. & Compli. Officer

Concord Drugs Ltd FAQs

How do I Buy Concord Drugs Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Concord Drugs Ltd shares in BlinkX.

What is the Share Price of Concord Drugs Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Concord Drugs Ltd's share price is ₹71 as of 2026-04-05.

What is the PE ratio of Concord Drugs Ltd?

close

Concord Drugs Ltd's P/E ratio is 124.56 times as of 2026-04-05.

What is the PB ratio of Concord Drugs Ltd?

close

Concord Drugs Ltd's most recent financial reports indicate a price-to-book ratio of 2.06, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Concord Drugs Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Concord Drugs Ltd's market capitalization is ₹71 Cr as on 2026-04-05.

What is the ROE of Concord Drugs Ltd?

close

The current financial records of Concord Drugs Ltd show a 0.88% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Concord Drugs Ltd?

close

According to Concord Drugs Ltd's most recent financial filings, the company has a total asset value of ₹33.42, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Concord Drugs Ltd?

close

The 52-week high/low price of a Concord Drugs Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Concord Drugs Ltd's 52-week high and low as of 2026-04-05 are ₹92.52 and ₹29, respectively.